T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Cameco
CCJ
$42.6B
| $125M | 0.02% |
13,509,681
+792,817
| +6% | +$7.43M |
|
577
Green Dot
GDOT
$770M
| $124M | 0.02% |
2,057,059
-83,670
| -4% | -$4.91M |
|
578
FB Financial Corp
FBK
$3.1B
| $124M | 0.02% |
2,950,572
+35,280
| +1% | +$1.43M |
|
|
INVX
579
Innovex International
INVX
$2.15B
| $122M | 0.02% |
2,547,749
-6,295
| -0.2% | -$281K |
|
|
BNCL
580
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $120M | 0.02% |
7,310,614
-17,919
| -0.2% | -$298K |
|
581
Mettler-Toledo International
MTD
$28.7B
| $120M | 0.02% |
193,942
-1,729
| -0.9% | -$1.11M |
|
|
EBSB
582
DELISTED
Meridian Bancorp, Inc.
EBSB
| $120M | 0.02% |
5,802,285
+57,646
| +1% | +$1.14M |
|
|
DST
583
DELISTED
DST Systems Inc.
DST
| $119M | 0.02% |
1,922,025
+9,577
| +0.5% | +$568K |
|
584
FIVE9
FIVN
$2.53B
| $119M | 0.02% |
4,789,386
+16,362
| +0.3% | +$404K |
|
585
Cardinal Health
CAH
$53.8B
| $119M | 0.02% |
1,938,020
+1,040,506
| +116% | +$64.3M |
|
586
Entegris
ENTG
$25B
| $118M | 0.02% |
3,886,761
+332,643
| +9% | +$10.2M |
|
587
Zillow
Z
$8.08B
| $117M | 0.02% |
2,863,965
+31,464
| +1% | +$1.29M |
|
588
Universal Health Services
UHS
$10.1B
| $117M | 0.02% |
1,031,029
-244,658
| -19% | -$26.1M |
|
589
Ryanair
RYAAY
$30.7B
| $116M | 0.02% |
2,789,693
+617,048
| +28% | +$27.5M |
|
|
RSPP
590
DELISTED
RSP Permian, Inc.
RSPP
| $116M | 0.02% |
2,850,272
+247,163
| +9% | +$8.88M |
|
591
Live Oak Bancshares
LOB
$2.01B
| $116M | 0.02% |
4,855,660
-145,603
| -3% | -$3.52M |
|
592
Boston Scientific
BSX
$74.9B
| $116M | 0.02% |
4,661,975
+2,254,532
| +94% | +$62.2M |
|
|
CKH
593
DELISTED
Seacor Holdings Inc.
CKH
| $115M | 0.02% |
2,496,975
-562,924
| -18% | -$25.9M |
|
594
Capital One
COF
$137B
| $115M | 0.02% |
1,158,691
+276,006
| +31% | +$25.2M |
|
595
Hanover Insurance
THG
$7.77B
| $115M | 0.02% |
1,066,213
+26,906
| +3% | +$2.78M |
|
596
Palo Alto Networks
PANW
$323B
| $115M | 0.02% |
4,762,500
-984,270
| -17% | -$23.9M |
|
597
ConocoPhillips
COP
$150B
| $115M | 0.02% |
2,087,186
-68,980
| -3% | -$3.55M |
|
598
Hope Bancorp
HOPE
$1.85B
| $114M | 0.02% |
6,246,062
-145,947
| -2% | -$2.65M |
|
599
Liberty Latin America Class C
LILAK
$1.65B
| $114M | 0.02% |
6,685,745
-161,651
| -2% | -$3.04M |
|
600
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.44B
| $114M | 0.02% |
4,720,196
-98,970
| -2% | -$2.37M |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.